Related references
Note: Only part of the references are listed.Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
Min Niu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition)
Song-Ze Ding et al.
GUT (2022)
Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
Iris Lansdorp-Vogelaar et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2021)
Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial
Young-Il Kim et al.
BMC GASTROENTEROLOGY (2021)
Clarithromycin versus furazolidone for naive Helicobacter pylori infected patients in a high clarithromycin resistance area
Chen Qiao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis
Akiko Kowada et al.
HELICOBACTER (2021)
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
Chang Seok Bang et al.
GUT MICROBES (2020)
Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases
Yao Chen et al.
MICROBIOLOGYOPEN (2020)
Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis
Sung Woo Ko et al.
HELICOBACTER (2019)
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
Qi Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition
Mototsugu Kato et al.
HELICOBACTER (2019)
Can the treatment duration be shortened in bismuth-containing therapies for Helicobacter pylori eradication?
Digdem Ozer Etik et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2019)
Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection
Wen Zhong Liu et al.
HELICOBACTER (2018)
Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
Alex H. -R. Leow et al.
JOURNAL OF DIGESTIVE DISEASES (2018)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
James K. Y. Hooi et al.
GASTROENTEROLOGY (2017)
Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan
Momoko Tsuda et al.
HELICOBACTER (2017)
Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on realworld data
Shinzo Hiroi et al.
BMJ OPEN (2017)
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication
Kai-feng Pan et al.
GUT (2016)
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Carlo A. Fallone et al.
GASTROENTEROLOGY (2016)
Role of bismuth in improving Helicobacter pylori eradication with triple therapy
Maria Pina Dore et al.
GUT (2016)
Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics
E. A. Marcus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
Bao-Zhu Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
Bao-Zhu Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Optimum duration of regimens for Helicobacter pylori eradication
Yuhong Yuan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Helicobacter pylori: clinical management
Peter Malfertheiner et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
Jun-Won Chung et al.
HELICOBACTER (2011)
Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days
Maria Pina Dore et al.
HELICOBACTER (2011)
Helicobacter pylori treatment in the era of increasing antibiotic resistance
David Y. Graham et al.
GUT (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Share Paper
